Das Krankenhaus der Barmherzigen Brüder ist ein Krankenhaus der Barmherzigen Brüder vom hl. Johannes von Gott in Linz.

During the past decade, KH der Barmherzigen Brüder Linz conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KH der Barmherzigen Brüder Linz" #1 sponsor was "Austrian Breast & Colorectal Cancer Study Group" with 3 trials, followed by "Bayer" with 3 trials sponsored, "Celgene" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KH der Barmherzigen Brüder Linz" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Granzer Regulatory Consulting & Services" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "KH der Barmherzigen Brüder Linz" are "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Breast Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "KH der Barmherzigen Brüder Linz" in a lesser frequency.

Most popular intervention types in "KH der Barmherzigen Brüder Linz" are "Drug" (12 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "GED-0301" (2 trials), "Ocrelizumab" (2 trials), "5-fluorouracil, levamisol, interferon" (1 trials) and "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials). Other intervention names were less common.

The vast majority of trials in "KH der Barmherzigen Brüder Linz" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "KH der Barmherzigen Brüder Linz". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in KH der Barmherzigen Brüder Linz, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in KH der Barmherzigen Brüder Linz, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".